BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16049973)

  • 1. Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients.
    Lomnytska M; Dubrovska A; Hellman U; Volodko N; Souchelnytskyi S
    Int J Cancer; 2006 Jan; 118(2):412-21. PubMed ID: 16049973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics success story. Towards early detection of breast and ovarian cancer: plasma proteomics as a tool to find novel markers.
    Souchelnytskyi S; Lomnytska M; Dubrovska A; Hellman U; Volodko N
    Proteomics; 2006 Sep; 6 Suppl 2():65-8. PubMed ID: 17031801
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tbx3 upregulation may be one of the malignant biomarkers of breast cancer].
    Chen ZH; Lv GM; Ji TH
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):765-7. PubMed ID: 19403417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of the imprinted gene ZAC by DNA methylation is an early event in the progression of human ovarian cancer.
    Kamikihara T; Arima T; Kato K; Matsuda T; Kato H; Douchi T; Nagata Y; Nakao M; Wake N
    Int J Cancer; 2005 Jul; 115(5):690-700. PubMed ID: 15751035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of TBX3 mRNA and its role in the pathogenesis and metastasis of breast cancer].
    Chen ZH; Lü GM; Ji TH
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):87-9. PubMed ID: 19218121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of ovarian cancer-associated proteins in symptomatic women: A novel method for semi-quantitative plasma proteomics.
    Shield-Artin KL; Bailey MJ; Oliva K; Liovic AK; Barker G; Dellios NL; Reisman S; Ayhan M; Rice GE
    Proteomics Clin Appl; 2012 Apr; 6(3-4):170-81. PubMed ID: 22532453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of humoral responses of ovarian cancer patients: antibody subclasses and antigenic components.
    Taylor DD; Atay S; Metzinger DS; Gercel-Taylor C
    Gynecol Oncol; 2010 Feb; 116(2):213-21. PubMed ID: 19945743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PMA-induced up-regulation of TBX3 is mediated by AP-1 and contributes to breast cancer cell migration.
    Mowla S; Pinnock R; Leaner VD; Goding CR; Prince S
    Biochem J; 2011 Jan; 433(1):145-53. PubMed ID: 20942798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TBX3 and its isoform TBX3+2a are functionally distinctive in inhibition of senescence and are overexpressed in a subset of breast cancer cell lines.
    Fan W; Huang X; Chen C; Gray J; Huang T
    Cancer Res; 2004 Aug; 64(15):5132-9. PubMed ID: 15289316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.
    Ye B; Skates S; Mok SC; Horick NK; Rosenberg HF; Vitonis A; Edwards D; Sluss P; Han WK; Berkowitz RS; Cramer DW
    Clin Cancer Res; 2006 Jan; 12(2):432-41. PubMed ID: 16428483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.
    Moshkovskii SA; Serebryakova MV; Kuteykin-Teplyakov KB; Tikhonova OV; Goufman EI; Zgoda VG; Taranets IN; Makarov OV; Archakov AI
    Proteomics; 2005 Sep; 5(14):3790-7. PubMed ID: 16121334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
    Kandimalla R; van Tilborg AA; Kompier LC; Stumpel DJ; Stam RW; Bangma CH; Zwarthoff EC
    Eur Urol; 2012 Jun; 61(6):1245-56. PubMed ID: 22284968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
    J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry.
    Tilleman K; Van Beneden K; Dhondt A; Hoffman I; De Keyser F; Veys E; Elewaut D; Deforce D
    Proteomics; 2005 May; 5(8):2247-57. PubMed ID: 15846842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
    Chen W; Salto-Tellez M; Palanisamy N; Ganesan K; Hou Q; Tan LK; Sii LH; Ito K; Tan B; Wu J; Tay A; Tan KC; Ang E; Tan BK; Tan PH; Ito Y; Tan P
    Genes Chromosomes Cancer; 2007 Mar; 46(3):288-301. PubMed ID: 17171680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic studies of early-stage and advanced ovarian cancer patients.
    Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
    Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of aberrations in one-carbon metabolism with molecular phenotype and grade of breast cancer.
    Naushad SM; Pavani A; Rupasree Y; Divyya S; Deepti S; Digumarti RR; Gottumukkala SR; Prayaga A; Kutala VK
    Mol Carcinog; 2012 Oct; 51 Suppl 1():E32-41. PubMed ID: 22086855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
    Yan XD; Pan LY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer.
    Jackson D; Craven RA; Hutson RC; Graze I; Lueth P; Tonge RP; Hartley JL; Nickson JA; Rayner SJ; Johnston C; Dieplinger B; Hubalek M; Wilkinson N; Perren TJ; Kehoe S; Hall GD; Daxenbichler G; Dieplinger H; Selby PJ; Banks RE
    Clin Cancer Res; 2007 Dec; 13(24):7370-9. PubMed ID: 18094419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of fibrinogen E-fragment and fibrin E-fragment is inhibited in the human infiltrating ductal carcinoma of the breast: the two-dimensional electrophoresis and MALDI-TOF-mass spectrometry analyses.
    Chahed K; Kabbage M; Ehret-Sabatier L; Lemaitre-Guillier C; Remadi S; Hoebeke J; Chouchane L
    Int J Oncol; 2005 Nov; 27(5):1425-31. PubMed ID: 16211239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.